Oravax Oral COVID-19 Vaccine Set to Begin Clinical Trials Medicine & Technology Mar 22, 2021 Oravax, a pharmaceutical company, is developing an oral COVID-19 vaccine that would be easier to store, ship, and administer as compared to commonly used intravenous vaccines.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts